On June 21, 2019, Peter Garcia informed PDL BioPharma, Inc. that he intends to resign as Vice President and Chief Financial Officer of the Company effective as of August 15, 2019, which is expected to be after the filing of the company's quarterly report on form 10-Q for the quarter ending June 30, 2019. Mr. Garcia will continue to serve as Vice President and Chief Financial Officer until such date.